Holen Sie sich die Stockscreener-App
21.86
0.26%
0.025
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$21.88
Offen:
$21.57
24-Stunden-Volumen:
36,856
Relative Volume:
0.02
Marktkapitalisierung:
$1.49B
Einnahmen:
$796.00M
Nettoeinkommen (Verlust:
$-136.49M
KGV:
-10.46
EPS:
-2.09
Netto-Cashflow:
$-64.24M
1W Leistung:
-6.29%
1M Leistung:
+11.58%
6M Leistung:
+71.52%
1J Leistung:
+22.62%
1-Tages-Spanne:
$21.52
$22.02
1-Wochen-Bereich:
$20.17
$23.22
52-Wochen-Spanne:
$9.98
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
21.86 | 1.43B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
109.92 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.58 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.93 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.88 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.38 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-23 | Hochstufung | Lake Street | Hold → Buy |
| 2026-02-20 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-01-27 | Fortgesetzt | TD Cowen | Buy |
| 2025-12-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | Fortgesetzt | Stifel | Hold |
| 2025-09-08 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-06-16 | Eingeleitet | Truist | Hold |
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2025-03-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Liquidity Mapping Around (TNDM) Price Events - Stock Traders Daily
[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
How Tandem Diabetes Care Inc. stock reacts to job market data2026 Opening Moves & Technical Analysis for Trade Confirmation - Naître et grandir
Why analysts maintain buy rating on Tandem Diabetes Care Inc. (TD5A) stockPortfolio Performance Summary & Weekly Breakout Watchlists - Naître et grandir
Is Tandem Diabetes Care Inc. stock a safe haven assetMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Naître et grandir
Breakout Move: Is Tandem Diabetes Care Inc stock influenced by commodity pricesMarket Growth Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Aug Retail: Is Tandem Diabetes Care Inc. stock a safe haven assetEarnings Risk Summary & Low Drawdown Trading Techniques - Naître et grandir
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know - Yahoo Finance
Medtronic’s MiniMed raises $560M in IPO priced below range - Modern Healthcare
Tandem Diabetes Care, Inc. $TNDM Position Trimmed by Vanguard Group Inc. - MarketBeat
Tandem Diabetes adds Android support for Mobi insulin pump - Investing.com Nigeria
Tandem Diabetes expands Mobi Insulin Pump to Android users - Medical Economics
Royce & Associates Invests in Tandem Diabetes Care - National Today
Royce & Associates LP Makes New Investment in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes adds Android support for Mobi insulin pump By Investing.com - Investing.com Canada
Tandem Mobi Android Launch Expands Access And Supports Recurring Revenue Story - Yahoo Finance
Tandem Diabetes Care Expands Tandem Mobi App Compatibility to Android Smartphones - geneonline.com
Tandem Diabetes at TD Cowen Conference: Shifting to a PAYGO Model - Investing.com
Tandem Mobi Now Compatible with Android Smartphones - Eagle-Tribune
TNDM Technical Analysis & Stock Price Forecast - Intellectia AI
Tandem Diabetes Care Bond Deal Reshapes Funding And Valuation Picture - simplywall.st
Tandem Diabetes Care Funding Move Tests Valuation And Acquisition Plans - simplywall.st
TNDM SEC FilingsTandem Diabetes 10-K, 10-Q, 8-K Forms - Stock Titan
Tandem Diabetes Care Receives Analyst Rating Upgrades - National Today
Morgan Stanley Maintains Equal-Weight, Raises PT for Tandem Diab - GuruFocus
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
FDA warns insulin infusion set maker Unomedical over leaks, mishandled complaints - MedTech Dive
Tandem Bests $1B Worldwide Sales - San Diego Business Journal
Why Tandem Diabetes Care Stock Popped Today - AOL.com
3 Healthcare Stocks We're Skeptical Of - Finviz
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Tandem Diabetes Care Experiences Revision in Its Stock Evaluation Amid Mixed Financial Trends - Markets Mojo
Tandem Diabetes Care Conference: Record 58% Margin, “Toby” Tubeless Mobi and Pharmacy Shift Ahead - MarketBeat
Assessing Tandem Diabetes Care (TNDM) Valuation After A Strong Recent Share Price Run - simplywall.st
Tandem Diabetes Care Hits Day High with 52.59% Surge in Stock Price - Markets Mojo
Tandem Diabetes Care Announces Convertible Senior Notes Offering - TipRanks
Tandem Diabetes Care Raises $300 Million in 0% Convertible Notes, Adds Capped Calls to Curb Dilution - TradingView
Tandem Diabetes Care (TNDM) prices $300M zero-coupon convertible notes due 2032 - Stock Titan
Tandem Diabetes Care prices $265M convertible debt offering - MSN
Envestnet Asset Management Inc. Cuts Stock Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care Beats Q4 Earnings Estimates - National Today
Tandem Diabetes Care (TNDM) price target increased by 19.37% to 29.72 - MSN
Tandem Diabetes Care (TNDM) Price Target Increased by 19.37% to 29.72 - Nasdaq
Tandem Diabetes Care (NASDAQ:TNDM) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Tandem Diabetes Care Hits Day High with 9.48% Surge in Stock Price - Markets Mojo
Tandem Diabetes prices $265M convertible notes offering - Investing.com
Tandem Diabetes prices $265M convertible notes offering By Investing.com - Investing.com South Africa
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032 - The AI Journal
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating the Healthcare Sector with a 2.30% Potential Upside - DirectorsTalk Interviews
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap DownHere's What Happened - MarketBeat
Tandem Diabetes plans $200M convertible notes offering By Investing.com - Investing.com India
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):